Warning: Undefined variable $page_cluster_id in /home3/thegood9/public_html/website_70aad9ea/header.php on line 29



Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Saturday, March 28, 2026




In Detail Full day, Saturday, March 28, 2026, Timezone: America/Chicago


When it comes to surgery, your doctor's leadership skills play a crucial role

medicalxpress - You're scheduled for surgery next week. You've likely looked up your surgeon's credentials, years of experience, and perhaps even patient reviews. You want reassurance that your surgeon has steady hands, deep expertise, and a thorough command of the proce…

AI Summary: New research links a surgeon’s leadership and team‑management skills to measurable differences in operating‑room performance and patient outcomes. Hospitals are being nudged to treat leadership training as clinical skill development rather than optional soft training — because apparently who’s in charge matters when someone’s insides are on the line.

#healthcare #publichealth #hospitaloperations

7 wks / oncodaily

7 wks / oncodaily

1 month / oncodaily

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress


Back to Top / Saturday, March 28, 2026, 3:21 pm / permalink 21469 / 10 stories in 2 months /

Global study estimates over 250,000 meningitis deaths in 2023, with young children bearing a heavy toll

medicalxpress - In 2023, 259,000 people died from meningitis and 2.5 million people were infected with the disease globally, suggests a study published in The Lancet Neurology. Although death and infection rates have declined significantly since 1990, progress is insuffi…

AI Summary: A worldwide mortality analysis estimates more than 250,000 deaths from meningitis in 2023, with young children bearing the heaviest toll. The findings underline gaps in vaccination, surveillance and outbreak preparedness, and call for accelerated prevention efforts—particularly on campuses and in high‑risk populations—before the predictable heartbreak rolls around again.

#healthcare #publichealth #governmentpolicy #infanthealth #infectiousdisease #healthdisparities

1 month / medicalxpress

2 months / medicalxpress

2 months / medicalxpress

2 months / bbc

2 months / medicalxpress


Back to Top / Saturday, March 28, 2026, 3:21 pm / permalink 21468 / 5 stories in 2 months /

Spatial mapping technique allows researchers to understand tumor architecture

medicalxpress - Tumors contain many different types of cells organized in complex spatial patterns that can influence how the disease progresses. Because of this, it is hard to predict how a tumor will develop and respond to treatment. Researchers at the University of Il…

AI Summary: Advanced spatial mapping techniques revealed how tumor architecture and local microenvironments reorganize — including changes driven by tumor‑linked viruses — altering immune cell positioning and signaling. The work provides a high‑resolution blueprint for understanding treatment resistance and suggests new targets for precision therapies that consider the tumor’s geographic biology, not just its genetics.

#pharmaceuticals #biotech #drugdevelopment #oncology #infectiousdisease #cancerresearch

Field report: Immune geography dictates therapy response and resistance

1 month / oncodaily

2 months / medicalxpress

2 months / oncodaily

2 months / oncodaily


On scene: microbes and viruses remap tumor microenvironments

1 month / medicalxpress

1 month / sciencedaily

2 months / oncodaily


On the ground: spatial multi-omics maps tumor architecture

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress


Other: Miscellaneous tumor biology, therapies, biomarkers

1 month / nature

1 month / medicalxpress

1 month / medicalxpress

1 month / medicalxpress

1 month / medicalxpress

1 month / medicalxpress

1 month / nature

1 month / medicalxpress

1 month / medicalxpress

2 months / medicalxpress

2 months / medicalxpress

2 months / oncodaily

2 months / oncodaily

2 months / nature

2 months / oncodaily

2 months / oncodaily

2 months / nature


All Other Stories

7 wks / oncodaily

7 wks / oncodaily

7 wks / oncodaily

1 month / oncodaily

1 month / sciencedaily

1 month / oncodaily

1 month / oncodaily


Back to Top / Saturday, March 28, 2026, 1:22 pm / permalink 21467 / 40 stories in 2 months /

Continuous wearable monitoring reduces time with low oxygen after surgery, study finds

medicalxpress - Patients continuously monitored after surgery experienced significantly less time with dangerously low oxygen levels compared to those monitored using routine spot checks, a new study from Wake Forest University School of Medicine found.

AI Summary: An HCA Florida hospital has named a new chief financial officer as part of a leadership shakeup aimed at stabilizing operations and tightening financial oversight. The appointment signals management’s focus on fiscal discipline and strategic planning amid ongoing industry pressures—because nothing says “confidence” like swapping out the person who signs the checks.

#healthcare #hospitaloperations #healthcarefinance

2 months / medicalxpress


Back to Top / Saturday, March 28, 2026, 9:21 am / permalink 21459 / 15 stories in 2 months /

A gut microbe linked to the Mediterranean diet boosts muscle strength in mice

livescience - Researchers are exploring the prospect of using gut bacteria to boost muscle strength, after zeroing in on a microbe that does this in mice

AI Summary: Researchers identified a gut microbe associated with adherence to a Mediterranean-style diet that, when introduced to mice, improved muscle strength and mitochondrial-related signals. The findings suggest a microbiome-mediated pathway that could inform interventions for age-related muscle decline, though translation to humans remains unproven and will need careful clinical follow-up.

#publichealth #biotech #clinicaltrials #nutrition #supplements

1 month / medicalxpress

2 months / medicalxpress

2 months / livescience

2 months / medicalxpress


Back to Top / Saturday, March 28, 2026, 8:21 am / permalink 21458 / 6 stories in 2 months /

AstraZeneca’s in vivo CAR-T led to early responses, but one death in China trial

Lei Lei Wu / endpoints - New clinical trial data on the in vivo CAR-T therapy that AstraZeneca acquired last year suggest that while the experimental treatment can curb multiple myeloma in some patients, it may not be safer than the ...

AI Summary: Early reports from a phase 1 in‑vivo CAR‑T program show promising anti‑myeloma activity following direct in‑body CAR induction targeting BCMA, but investigators also reported a treatment‑related death in a China trial. The mixed signals underscore the potential of in‑vivo CAR approaches while spotlighting safety, dosing and monitoring challenges that must be resolved before wider adoption.

#pharmaceuticals #biotech #drugdevelopment #oncology #cancerresearch #clinicaltrials

AstraZeneca's in‑vivo CAR‑T: early wins, serious safety questions

2 months / oncodaily

2 months / oncodaily

2 months / nature / Ning An


Myeloma community reacts: experts, conferences and paper highlights

1 month / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily


Next‑gen T‑cell strategies and regulatory hurdles

1 month / oncodaily

2 months / oncodaily

2 months / medicalxpress


All Other Stories

7 wks / oncodaily

1 month / oncodaily

1 month / oncodaily

1 month / oncodaily

1 month / oncodaily


Back to Top / Saturday, March 28, 2026, 7:21 am / permalink 21455 / 20 stories in 2 months /

EMA Recommends Granting a Conditional Marketing Authorisation for Tovorafenib

esmo - It is intended for the treatment of paediatric patients with low-grade glioma with BRAF alterations whose disease has progressed after one or more prior systemic therapies

AI Summary: Five‑year results from KEYNOTE‑671 indicate perioperative pembrolizumab yields sustained clinical benefit in early‑stage non‑small‑cell lung cancer, improving outcomes even when pathological complete response is not achieved. The data bolster the case for integrating immune checkpoint blockade into surgical-era treatment strategies, shifting conversations about neoadjuvant and adjuvant sequencing.

#pharmaceuticals #biotech #drugdevelopment #oncology #cancerresearch #clinicaltrials

Frontline precision: KRAS G12D and EGFR targeted advances in NSCLC

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily


Insider view: evolving IO biology, toxicity and access debates

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily


On-the-ground: Neoadjuvant immunotherapy and radiotherapy reshaping lung surgery

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily


OTHER: assorted oncology updates outside perioperative NSCLC focus

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / esmo


All Other Stories

1 month / oncodaily


Back to Top / Saturday, March 28, 2026, 7:21 am / permalink 21454 / 16 stories in 2 months /

When everyday tasks become harder: Early clues to Alzheimer's disease

medicalxpress - For many older adults, life is full of routines. Making breakfast, paying bills, shopping, driving, managing appointments and keeping track of medications are tasks done almost automatically. For most, these routines run smoothly, but for some, small disr…

AI Summary: A study finds that small, progressive difficulties with routine daily tasks can be early indicators of Alzheimer’s disease, preceding obvious cognitive symptoms. Tracking functional changes may enable earlier detection, intervention and planning, shifting attention from memory tests alone to how people manage everyday life — yes, the missing teaspoons matter.

#healthcare #publichealth #digitalhealth #behavioralhealth

Everyday task declines: early, subtle signals of pending Alzheimer’s

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress


Labs and trials wrestle with hopeful but faltering Alzheimer's therapies

2 months / medicalxpress


Sleep, blood and life-history markers expose rising dementia risk

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress


All Other Stories

1 month / medicalxpress

1 month / medicalxpress

1 month / medicalxpress

1 month / medicalxpress

1 month / medicalxpress

1 month / medicalxpress

1 month / bbc

2 months / medicalxpress

2 months / medicalxpress


Back to Top / Saturday, March 28, 2026, 6:23 am / permalink 21451 / 23 stories in 2 months /

Results from the Phase 2 POLAR Trial: Pembrolizumab and Olaparib in HRD Metastatic Pancreatic Cancer

oncodaily - Pancreatic cancer remains one of the most challenging malignancies to treat, particularly in the metastatic setting, where immunotherapy has historically shown minimal activity. However, a biologically defined subset of patients […]

AI Summary: The Phase 2 POLAR trial presented results evaluating pembrolizumab combined with olaparib in homologous recombination–deficient metastatic pancreatic cancer, including safety, response rates and biomarker analyses. Investigators observed signals of activity in HRD‑selected patients, suggesting the immunotherapy–PARP inhibitor combination merits larger randomized testing rather than immediate headline glory.

#pharmaceuticals #biotech #drugdevelopment #oncology #pancreaticcancer #cancerresearch #clinicaltrials

2 months / medicalxpress

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily


Back to Top / Saturday, March 28, 2026, 1:22 am / permalink 21444 / 6 stories in 2 months /

UK government recommends maximum two hours of screen time for younger children: What the evidence says

medicalxpress - New UK government guidance recommends that screen time for children under two should be avoided, except for shared activities such as video calls. For children aged two to five, a maximum of an hour a day is suggested. The guidance also outlines that watc…

AI Summary: The UK government updated child‑health guidance recommending strict limits on young children’s screen time, citing evidence linking excessive use to delayed development and poorer sleep. The guidance urges parents and caregivers to prioritize interactive, non‑screen activities and age‑appropriate limits while acknowledging modern practicalities for families.

#healthcare #publichealth #governmentpolicy #infanthealth #digitalhealth #behavioralhealth

2 months / medicalxpress

2 months / medicalxpress

2 months / medicalxpress

2 months / bbc


Back to Top / Saturday, March 28, 2026, 12:23 am / permalink 21439 / 4 stories in 2 months /

FDA flags misleading claims for cancer drug by biotech billionaire Patrick Soon-Shiong

abcnews - Federal health officials have issued a warning about controversial statements made by biotech billionaire Dr. Patrick Soon-Shiong about one of his company's cancer drugs

AI Summary: The FDA issued warnings over promotional materials and public statements related to a cancer drug associated with a biotech entrepreneur, finding claims that could mislead patients and investors. The agency asked the company to correct materials and refrain from unsubstantiated efficacy or safety assertions while oversight and compliance reviews continue.

#healthcare #pharmaceuticals #biotech #drugdevelopment #fda #oncology #cancerresearch #clinicaltrials #venturecapital

2 months / medicalxpress

2 months / abcnews


Back to Top / Saturday, March 28, 2026, 12:23 am / permalink 21438 / 4 stories in 2 months /

FDA approves Rocket's gene therapy for ultra-rare immune disease

Lei Lei Wu / endpoints - A rare disease gene therapy from Rocket Pharmaceuticals has garnered FDA approval after an earlier rejection for manufacturing problems. The FDA on Thursday granted accelerated approval to Rocket Pharma’s gene therapy ...

AI Summary: The FDA granted approval to Rocket’s gene therapy for a pediatric immune disorder, marking the first regulatory ok for this specific treatment class in children and offering a one‑time corrective option for affected patients. The decision opens access while raising expectations for long‑term follow‑up and real‑world safety monitoring.

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda #infanthealth #clinicaltrials

2 months / medicalxpress


Back to Top / Saturday, March 28, 2026, 12:23 am / permalink 21435 / 5 stories in 2 months /

Merck’s $6.7B Terns Acquisition Positions It to Challenge a Blockbuster Novartis Cancer Drug

Frank Vinluan / medcitynews - Merck has been acquiring assets that could help make up for the coming revenue decline as its top product, the cancer drug Keytruda, drops off the patent cliff. Terns Pharmaceuticals’ lead product candidate, in development for treating a type of leukemia,…

AI Summary: Merck announced a definitive deal to acquire Terns Pharmaceuticals for about $6.7 billion, gaining a promising leukemia drug candidate and bolstering its oncology pipeline. The transaction aims to combine Merck’s late‑stage development and commercialization capabilities with Terns’ targeted therapy assets to compete in hematologic malignancies.

#pharmaceuticals #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment #oncology #healthcarefinance #cancerresearch #clinicaltrials

2 months / medicalxpress


Back to Top / Saturday, March 28, 2026, 12:23 am / permalink 21434 / 4 stories in 2 months /

Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows

medicalxpress - New evidence from a Chinese cohort presented at the European Lung Cancer Congress (ELCC) 2026 shows that one-time low-dose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in a non–risk based population, including indivi…

AI Summary: A large population‑based study found organized lung cancer screening reduced mortality even in people who never smoked, demonstrating the benefits of expanded CT screening criteria and systematic outreach. The results suggest screening programs can detect lethal disease earlier across broader risk groups, prompting reconsideration of current eligibility rules.

#healthcare #publichealth #governmentpolicy #oncology #cancerresearch #cancerscreening #healthdisparities

1 month / esmo

1 month / medicalxpress

2 months / oncodaily

2 months / medicalxpress

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / medicalxpress

2 months / esmo


Back to Top / Saturday, March 28, 2026, 12:22 am / permalink 21432 / 12 stories in 2 months /



StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Infectious Disease, Biotech, Price Transparency, Weight Loss and look for the RSS link.

More StackHealth





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.